Biliary Tract Tumors: Update in Diagnosis and Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 261
Special Issue Editor
Special Issue Information
Dear Colleagues,
Biliary tract tumors comprise a diverse group of epithelial hepatic and perihepatic malignancies that emerge from the biliary tree. They are a heterogeneous group with very different characteristics depending on the anatomically distinct primary site. The anatomic subtypes comprise gallbladder tumor, extrahepatic and intrahepatic tumor, and ampulla of Vater tumor. These are rare in most of the world, and their subtypes vary greatly between geographic regions; they are diagnosed most frequently in East Asian and South American countries. The incidence and mortality rates, including the overall increase in mortality rates, emphasize the unmet needs for improved diagnosis and treatment for biliary tract tumors.
In recent years, there have been many advances in the diagnosis of tumors using advanced molecular techniques, including NGS and the development of liquid biopsy. In terms of treatment, surgical resection is still the most important treatment for curative intents, and there have been advances in endoscopic resection and local ablative therapy, including radiofrequency ablation. In addition, the application of chemotherapy, radiotherapy, and immuno-oncology drugs has also recently shown promising results.
This Special Issue of Cancers therefore encompasses new research articles and timely reviews on all aspects of diagnosis and treatment in biliary tract tumors.
Dr. Joo-Kyung Park
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bile duct tumor
- ampulla of vater tumor
- neuroendocrine tumor
- chemotherapy
- radiotherapy
- ERCP
- EUS
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
